Porphyrin derivatives
    43.
    发明授权
    Porphyrin derivatives 失效
    卟啉衍生物

    公开(公告)号:US4658023A

    公开(公告)日:1987-04-14

    申请号:US589281

    申请日:1984-03-14

    申请人: Koichi Shudo

    发明人: Koichi Shudo

    CPC分类号: C07D471/14

    摘要: Porphyrin derivatives containing a dipyrido[1,2-a:3',2'-d]imidazole moiety and a porphyrin moiety therein and metal complexes thereof are disclosed. These derivatives possess enhanced oxygen-dependent DNA cleaving ability and are effective as anititumer agents.

    摘要翻译: 公开了含有二吡啶并[1,2-a:3',2'-d]咪唑部分和卟啉部分的卟啉衍生物及其金属络合物。 这些衍生物具有增强的氧依赖性DNA切割能力,并且作为药剂有效。

    5-membered heterocyclic compound
    45.
    发明授权
    5-membered heterocyclic compound 失效
    5元杂环化合物

    公开(公告)号:US08722730B2

    公开(公告)日:2014-05-13

    申请号:US12673177

    申请日:2008-08-14

    IPC分类号: A61K31/341 C07D307/40

    摘要: A compound represented by the following general formula (I): [wherein R1 and R2 represent an alkyl group, X represents —S—, —O— or —NH—, Y represents C or N, R3 represents hydrogen atom or a C1-10 alkyl group, Z represents —CO—N(R5)— (R5 represents hydrogen atom or a C1-6 alkyl group) or —C(R6)═C(R7)—CO—NH— (R6 and R7 represent hydrogen atom or a C1-6 alkyl group), Ar represents an aryldiyl group or a heteroaryldiyl group, and R4 represents —COOH, —OCH2—COOH, —CH2—COOH, or —CH2—CH2—COOH], which has a retinoid action and is useful as an active ingredient of a medicament.

    摘要翻译: 由下列通式(I)表示的化合物:[其中R1和R2表示烷基,X表示-S-,-O-或-NH-,Y表示C或N,R3表示氢原子或C1- 10表示烷基,Z表示-CO-N(R5) - (R5表示氢原子或C1-6烷基)或-C(R6)= C(R7)-CO-NH-(R6和R7表示氢原子 或C 1-6烷基),Ar表示芳基二基或杂芳基二基,R 4表示-COOH,-OCH 2 -COOH,-CH 2 -COOH或-CH 2 -CH 2 -COOH],其具有类视黄醇作用和 可用作药物的活性成分。

    DEUTERATED PHENYLPROPIONIC ACID DERIVATIVE
    46.
    发明申请
    DEUTERATED PHENYLPROPIONIC ACID DERIVATIVE 审中-公开
    去除苯丙酸衍生物

    公开(公告)号:US20140121407A1

    公开(公告)日:2014-05-01

    申请号:US14126460

    申请日:2012-07-04

    IPC分类号: C07C235/74

    摘要: A compound corresponding to 3-[4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]phenyl]propionic acid in which a part or all of hydrogen atoms in the ethylene group constituting the propionic acid moiety are replaced with deuterium atoms, a salt thereof, or an ester thereof, and a prodrug for releasing Am80 as an active medicament after being absorbed into a living body, which comprises the aforementioned compound, a salt thereof, or an ester thereof as an active ingredient.

    摘要翻译: 对应于其中部分或全部氢原子的3- [4 - [(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)氨基甲酰基]苯基]丙酸的化合物 在构成丙酸部分的亚乙基中被氘原子取代,其盐或其酯,以及用于在被吸收到生物体中后作为活性药物释放的前药,其包含上述化合物,盐 或其酯作为活性成分。

    Retinoid prodrug compound
    47.
    发明授权
    Retinoid prodrug compound 失效
    维甲酸前药化合物

    公开(公告)号:US08633335B2

    公开(公告)日:2014-01-21

    申请号:US12682966

    申请日:2007-10-31

    IPC分类号: C07C51/367

    摘要: A compound represented by the following general formula (I): [R1 to R5 represent hydrogen atom, an alkyl group, or a trialkylsilyl group, X represents —NH—CO—, —CO—NH—, —N(COR6)—CO—, —CO—N(COR7)— (R6 and R7 represent a lower alkoxy group, or a carboxy-substituted phenyl group) etc.; and Z represents —Y—CH(R12)—COOH, —CHO, —CH═CH—COOH, or —COOR13 (Y represents a single bond, —CH2—, —CH(OH)—, —CO—, —CO—NH—, or —CO—NH—CH2—CO—NH—, R12 represents hydrogen atom or a lower alkyl group, and R13 represents hydrogen atom, —CH(R14)—COOH(R14 represents hydrogen atom, a lower alkyl group, or hydroxy group), —[CH2CH2—O]n—CH2—CH2—OH, —CH2—O—[CH2CH2—O]m—CH2—OH, or —[CH(CH3)—CO—O]p—CH(CH3)—COOH (m, n and p represent an integer of 1 to 100))], a salt thereof or an ester thereof, which has a property of being converted into a retinoid after absorption in vivo.

    摘要翻译: 由以下通式(I)表示的化合物:[R1至R5表示氢原子,烷基或三烷基甲硅烷基,X表示-NH-CO-,-CO-NH-,-N(COR6)-CO - ,-CO-N(COR 7) - (R 6和R 7表示低级烷氧基或羧基取代的苯基)等。 Z表示-Y-CH(R 12)-COOH,-CHO,-CH = CH-COOH或-COOR 13(Y表示单键,-CH 2 - , - CH(OH) - , - CO- -NH-或-CO-NH-CH 2 -CO-NH-,R 12表示氢原子或低级烷基,R 13表示氢原子,-CH(R 14)-COOH(R ​​14表示氢原子,低级烷基 ,或羟基), - [CH 2 CH 2 -O] n -CH 2 -CH 2 -OH,-CH 2 -O- [CH 2 CH 2 -O] m -CH 2 -OH或 - [CH(CH 3)-CO-O] CH(CH 3)-COOH(m,n和p表示1〜100的整数))],其盐或其酯,其在体内吸收后具有转化为类视黄醇的性质。

    Tricyclic amide compound
    48.
    发明授权
    Tricyclic amide compound 失效
    三环酰胺化合物

    公开(公告)号:US08232300B2

    公开(公告)日:2012-07-31

    申请号:US12673207

    申请日:2008-08-14

    摘要: A compound represented by the following general formula (I): [wherein R1 represents hydrogen atom or a C1-6 alkyl group, A and B represent —(CH2)2—, —(CH2)3—or —(CH2)4—, X represents —N(R2)—CO—(R2 represents hydrogen atom or a C1-6 alkyl group), —CO—N(R3)—(R3 represents hydrogen atom or a C1-6 alkyl group), —C(R4)═C(R5)—(R4 and R5 represent hydrogen atom or a C1-6 alkyl group), or —N(R6)—SO2—(R6 represents hydrogen atom or a C1-6 alkyl group), and Ar represents an aryldiyl group or a heteroaryldiyl group], which has a retinoid action and is useful as an active ingredient of a medicament.

    摘要翻译: 由以下通式(I)表示的化合物:其中R 1表示氢原子或C 1-6烷基,A和B表示 - (CH 2)2 - , - (CH 2)3 - 或 - (CH 2)4 - ,X表示-N(R 2)-CO-(R 2表示氢原子或C 1-6烷基),-CO-N(R 3) - (R 3表示氢原子或C 1-6烷基), - C R4)= C(R5) - (R4和R5代表氢原子或C1-6烷基)或-N(R6)-SO2-(R6代表氢原子或C1-6烷基),Ar代表 芳基二基或杂芳基二基],其具有类视黄醇作用并且可用作药物的活性成分。

    TRICYCLIC AMIDE COMPOUND
    49.
    发明申请
    TRICYCLIC AMIDE COMPOUND 失效
    三酰胺化合物

    公开(公告)号:US20110213157A1

    公开(公告)日:2011-09-01

    申请号:US12673207

    申请日:2008-08-14

    摘要: A compound represented by the following general formula (I): [wherein R1 represents hydrogen atom or a C1-6 alkyl group, A and B represent —(CH2)2—, —(CH2)3— or —(CH2)4—, X represents —N(R2)—CO— (R2 represents hydrogen atom or a C1-6 alkyl group), —CO—N(R3)— (R3 represents hydrogen atom or a C1-6 alkyl group), —C(R4)═C(R5)— (R4 and R5 represent hydrogen atom or a C1-6 alkyl group), or —N(R6)—SO2— (R6 represents hydrogen atom or a C1-6 alkyl group), and Ar represents an aryldiyl group or a heteroaryldiyl group], which has a retinoid action and is useful as an active ingredient of a medicament.

    摘要翻译: 由下列通式(I)表示的化合物:[其中R1表示氢原子或C1-6烷基,A和B表示 - (CH2)2-, - (CH2)3-或 - (CH2)4- ,X表示-N(R 2)-CO-(R 2表示氢原子或C 1-6烷基),-CO-N(R 3) - (R 3表示氢原子或C 1-6烷基), - C R4)= C(R5) - (R4和R5代表氢原子或C1-6烷基)或-N(R6)-SO2-(R6代表氢原子或C1-6烷基),Ar代表 芳基二基或杂芳基二基],其具有类视黄醇作用并且可用作药物的活性成分。